Guillaume is currently Business Consultant Director at Dassault Systèmes (3DS). He is part of the Life Sciences organization that is responsible for creating and developing Dassault Systèmes strategy and associated solutions for pharmaceutical, medical devices and patient care industry customers. He focuses on topics such as precision health, digital therapeutics, total quality, knowledge capitalization, development and manufacturing excellence and re-inventing the value chain. Since joining the company, Guillaume has worked with leading life sciences companies and lab automation & quality software editors to develop and support business strategies in the areas of patient experience, product development and cross-enterprise collaboration. Guillaume has a Master Research Degree in Endocrinology and a Master Degree in BioInformatics.
Mrs Lambert studied in France and Singapore at Technological Universities and holds a degree in Bioengineering. She started her career at Servier Pharmaceuticals and St Jude Medical, and had the opportunity to demonstrate her proactivity and creativity. Her professional experience and passion for digital and innovative projects in Life Sciences has led her to join Dassault Systèmes in 2012. In the Life Sciences Industry team, she took over the definition of the solution “Designed to Cure” that focused on Biological Systems Modeling. In 2017, Mrs Lambert expanded her scope to Manufacturing & Supply Chain with “Made to Cure” Solution. She participated in defining and promoting the value of Digital Twins in Pharma Manufacturing. In parallel, she led the IASO project, a showcase for the lifecycle of a combination product in oncology. Following those successful projects, in 2019 she was promoted to advise and support a member of Dassault Systèmes’ executive commitee. After those very enriching experiences, she recently took over the definition of the global Life Sciences Portfolio.